COVID-19 Testing - Revision history

Bes at 15:47, 14 July 2020

2020-07-14T15:47:30Z

Bes at 15:41, 14 July 2020

2020-07-14T15:41:02Z

Bes at 15:38, 14 July 2020

2020-07-14T15:38:36Z

Bes at 15:38, 14 July 2020

2020-07-14T15:38:22Z

Bes at 15:38, 14 July 2020

2020-07-14T15:38:11Z

Bes at 15:36, 14 July 2020

2020-07-14T15:36:19Z

Bes: Created page with " From the CDC Webpage... [https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcr..."

2020-07-14T15:35:46Z

Created page with " From the CDC Webpage... [https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcr..."

New page

From the CDC Webpage...

[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html
"The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection."]

@@ Line 9: / Line 9: @@
 [https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."]
+===Illinois Department of Public Health===
-===Illinois Public Health Laboratories===
+:- [https://dph.illinois.gov/ Main Page]
-[https://dph.illinois.gov/topics-services/lab-testing-services Illinois Department of Public Health: Lab Testing and Services]
+:- [https://dph.illinois.gov/topics-services/lab-testing-services Illinois Department of Public Health: Lab Testing and Services]

← Older revision		Revision as of 15:41, 14 July 2020
Line 8:		Line 8:

	[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."]		[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."]
		+
		+
		+	===Illinois Public Health Laboratories===
		+	[https://dph.illinois.gov/topics-services/lab-testing-services Illinois Department of Public Health: Lab Testing and Services]

← Older revision		Revision as of 15:38, 14 July 2020
Line 7:		Line 7:
	Additionally, the following is posted at the same webpage...		Additionally, the following is posted at the same webpage...

−	[[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."]	+	[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."]

@@ Line 3: / Line 3: @@
 [https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection."]
 Additionally, the following is posted at the same webpage...
 [[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."]

← Older revision		Revision as of 15:38, 14 July 2020
Line 3:		Line 3:

	[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection."]		[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection."]
		+
		+	Additionally, the following is posted at the same webpage...
		+
		+	[[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Test kits are in production and will be shipped to public health laboratories once production, including quality control and assembly, has been completed."]

← Older revision		Revision as of 15:36, 14 July 2020
Line 2:		Line 2:
	From the CDC Webpage...		From the CDC Webpage...

−	[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html	+	[https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html "The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection."]
−	"The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The assay provides a sensitive, nucleic-acid-based diagnostic tool for evaluation of specimens from patients in the acute phase of infection."]